E-ISSN 2063-5346
 
2022, Vol: 11, Issue: 4
11/4Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Research Article 


PREPARATION AND CHARACTERIZATION OF LIPIDPOLYMER-HYBRID NANO PARTICLES OF ANTIALZHEIMER’S DRUGS- A RESEARCH

YELLAREDDY CHALLA, V. SENTHIL, N. JAWAHAR.

Abstract
Tramiprosate and luteolin are used as a means of treating Alzheimer's disease. Tramiprosate is a GABA-A
receptor functional agonist due to this structure being similar to the GABA structure. Due to its tremendous antioxidant
action, luteolin may be able to reduce the neurotoxicity of Aβ fragment 25-35 (Aβ 25-35) in the cortical neurons of mice. It
has been widely established that neuroinflammation and glutamatergic excitotoxicity, which are linked to neuronal
dysfunction and that they both contribute significantly to the onset and development of both locomotor and neurocognitive
diseases. The goals of this work were to characterise and examine the physicochemical features of each solid form of an
active pharmaceutical ingredient (API), each of which can display distinct physicochemical characteristics.

Key words: Alzheimer’s disease, Gama Amino Butyric Acid, Amyloid beta, Lipid-Polymer Hybrid Nanoparticles.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by YELLAREDDY CHALLA
Articles by V. SENTHIL
Articles by N. JAWAHAR
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

YELLAREDDY CHALLA, V. SENTHIL, N. JAWAHAR. PREPARATION AND CHARACTERIZATION OF LIPIDPOLYMER-HYBRID NANO PARTICLES OF ANTIALZHEIMER’S DRUGS- A RESEARCH. ECB. 2022; 11(4): 31-40. doi:10.31838/ecb/2022.11.04.005

Web Style

YELLAREDDY CHALLA, V. SENTHIL, N. JAWAHAR. PREPARATION AND CHARACTERIZATION OF LIPIDPOLYMER-HYBRID NANO PARTICLES OF ANTIALZHEIMER’S DRUGS- A RESEARCH. https://www.eurchembull.com/?mno=96463 [Access: August 09, 2022]. doi:10.31838/ecb/2022.11.04.005

AMA (American Medical Association) Style

YELLAREDDY CHALLA, V. SENTHIL, N. JAWAHAR. PREPARATION AND CHARACTERIZATION OF LIPIDPOLYMER-HYBRID NANO PARTICLES OF ANTIALZHEIMER’S DRUGS- A RESEARCH. ECB. 2022; 11(4): 31-40. doi:10.31838/ecb/2022.11.04.005


Vancouver/ICMJE Style

YELLAREDDY CHALLA, V. SENTHIL, N. JAWAHAR. PREPARATION AND CHARACTERIZATION OF LIPIDPOLYMER-HYBRID NANO PARTICLES OF ANTIALZHEIMER’S DRUGS- A RESEARCH. ECB. (2022), [cited August 09, 2022]; 11(4): 31-40. doi:10.31838/ecb/2022.11.04.005


Harvard Style

YELLAREDDY CHALLA, V. SENTHIL, N. JAWAHAR (2022) PREPARATION AND CHARACTERIZATION OF LIPIDPOLYMER-HYBRID NANO PARTICLES OF ANTIALZHEIMER’S DRUGS- A RESEARCH. ECB, 11 (4), 31-40. doi:10.31838/ecb/2022.11.04.005


Turabian Style

YELLAREDDY CHALLA, V. SENTHIL, N. JAWAHAR. 2022. PREPARATION AND CHARACTERIZATION OF LIPIDPOLYMER-HYBRID NANO PARTICLES OF ANTIALZHEIMER’S DRUGS- A RESEARCH. European Chemical Bulletin, 11 (4), 31-40. doi:10.31838/ecb/2022.11.04.005


Chicago Style

YELLAREDDY CHALLA, V. SENTHIL, N. JAWAHAR. "PREPARATION AND CHARACTERIZATION OF LIPIDPOLYMER-HYBRID NANO PARTICLES OF ANTIALZHEIMER’S DRUGS- A RESEARCH." European Chemical Bulletin 11 (2022), 31-40. doi:10.31838/ecb/2022.11.04.005


MLA (The Modern Language Association) Style

YELLAREDDY CHALLA, V. SENTHIL, N. JAWAHAR. "PREPARATION AND CHARACTERIZATION OF LIPIDPOLYMER-HYBRID NANO PARTICLES OF ANTIALZHEIMER’S DRUGS- A RESEARCH." European Chemical Bulletin 11.4 (2022), 31-40. Print. doi:10.31838/ecb/2022.11.04.005


APA (American Psychological Association) Style

YELLAREDDY CHALLA, V. SENTHIL, N. JAWAHAR (2022) PREPARATION AND CHARACTERIZATION OF LIPIDPOLYMER-HYBRID NANO PARTICLES OF ANTIALZHEIMER’S DRUGS- A RESEARCH. European Chemical Bulletin, 11 (4), 31-40. doi:10.31838/ecb/2022.11.04.005


Author Login Reviewer Login About Publisher Editorial Policies Peer Review Policy Editorial & Peer Review Process Author's Rights and Obligations Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights) Privacy Policy Publication Ethics and Publication Malpractice Statement Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.
The articles in European Chemical Bulletin are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Copyright © 2022 European Chemical Bulletin All Rights Reserved. Subject to change without notice from or liability to European Chemical Bulletin.
For best results, please use Internet Explorer or Google Chrome

Contact Information


European Chemical Bulletin

Budapest, Near Széchenyi István tér,

1051 Hungary

Email : editor@eurchembull.com